Bayer Aktiengesellschaft

BAYN.SG

Drug Manufacturers - General · Healthcare

Exchange

Stuttgart Stock Exchange

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Strong

Growth

Weak

Cash Flow

Weak

Stability

Weak

Valuation

Data not available

Dividends

Weak

Track this stock — start free trial

Winston Score History

The full picture

Bayer is a large German company that makes medicines, crop protection products, and consumer health items. Its pharmaceutical division sells drugs for conditions like heart disease, cancer, and eye disorders — with Xarelto (a blood thinner) and Eylea (an eye treatment) among its best-known products. Its crop science division sells pesticides, herbicides, and seeds to farmers worldwide, and it owns the Monsanto brand after a major acquisition in 2018.

Bayer earns money by selling prescription drugs to hospitals and pharmacies, agricultural chemicals and seeds to farmers, and over-the-counter health products to consumers. It operates globally, with significant revenue from Europe, North America, and Asia, and reported roughly $47 billion in market value as of mid-2026. The company's biggest ongoing challenge is massive legal liability tied to Roundup weedkiller lawsuits, which have cost billions in settlements and continue to weigh on its finances and investor confidence.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+1.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+215.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

€5.1B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Bayer Aktiengesellschaft is growing revenue at 1% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

58.2%

Premium pricing power — 58.2% gross margin

Profit after running costs

Operating Margin

7.6%

Modest — 7.6% operating margin

Return on the money invested

ROCE

21.0%

Exceptional — 21.0% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-1.7%

Shrinking sales (-1.7% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

3.2%

Thin free cash flow (3.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

2.43x

Tight — interest eats into profit (2.4x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

0.23%

no trend

Small dividend — 0.23% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

-71.6%

no trend

Dividend cut (-71.6% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial